Hikma Pharmaceuticals
$16.53
427
-$0.77-4.42% Thursday 13:30
Statistics
Day High
16.4
Day Low
16.4
52W High
27.96
52W Low
16.34
Volume
610
Avg. Volume
183
Mkt Cap
0
P/E Ratio
14.56
Dividend Yield
4.99%
Dividend
0.82
Upcoming
Dividends
4.99%Dividend Yield
Apr 26
$0.48
Sep 25
$0.36
May 25
$0.48
Sep 24
$0.32
May 24
$0.47
10Y Growth
9.74%
5Y Growth
10.47%
3Y Growth
7.74%
1Y Growth
-1.98%
Earnings
26FebExpected
Expected EPS
79.7513223
Actual EPS
N/A
Financials
11.48%Profit Margin
Profitable3.13BRevenue
359MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow HKMPF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Novartis
NVS
Mkt Cap237.61B
Pfizer
PFE
Mkt Cap140.15B
Abbvie
ABBV
Mkt Cap385.18B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Merck
MRK
Mkt Cap214.76B
GSK
GSK
Mkt Cap94.51B
Sanofi
SNY
Mkt Cap124.45B
Astrazeneca
AZN
Mkt Cap256.58B
About
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Show more...
CEO
H.E Said Samih Taleb Darwazah
Employees
9500
Country
GB
ISIN
GB00B0LCW083
Listings
0 Comments
Share your thoughts
FAQ
What is Hikma Pharmaceuticals stock price today?▼
The current price of HKMPF is $16.53 USD — it has decreased by -4.42% in the past 24 hours. Watch Hikma Pharmaceuticals stock price performance more closely on the chart.
What is Hikma Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hikma Pharmaceuticals stocks are traded under the ticker HKMPF.
Is Hikma Pharmaceuticals stock price growing?▼
HKMPF stock has risen by +0.79% compared to the previous week, the month change is a -8.17% fall, over the last year Hikma Pharmaceuticals has showed a -36.9% decrease.
When is the next Hikma Pharmaceuticals earnings date?▼
Hikma Pharmaceuticals is going to release the next earnings report on August 06, 2026.
What is Hikma Pharmaceuticals revenue for the last year?▼
Hikma Pharmaceuticals revenue for the last year amounts to 3.13B USD.
What is Hikma Pharmaceuticals net income for the last year?▼
HKMPF net income for the last year is 359M USD.
Does Hikma Pharmaceuticals pay dividends?▼
Yes, HKMPF dividends are paid semi-annual. The last dividend per share was 0.36 USD. As of today, Dividend Yield (FWD)% is 4.99%.
How many employees does Hikma Pharmaceuticals have?▼
As of April 03, 2026, the company has 9,500 employees.
In which sector is Hikma Pharmaceuticals located?▼
Hikma Pharmaceuticals operates in the Health Care sector.
When did Hikma Pharmaceuticals complete a stock split?▼
Hikma Pharmaceuticals has not had any recent stock splits.
Where is Hikma Pharmaceuticals headquartered?▼
Hikma Pharmaceuticals is headquartered in London, GB.